Related Experiment Video
Updated: Apr 21, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Systemic bevacizumab leads to resolution of diabetic macular edema
Justis P Ehlers1, Sharon Fekrat
1From the Vitreoretinal Service, Duke Eye Center, Duke University Medical Center, Durham, North Carolina.
Purpose:
The purpose of this study is to report a case of diabetic macular edema that resolved after systemic bevacizumab.
Methods:
This is an observational case report of a patient with diabetic macular edema.
Results:
After initiation of systemic bevacizumab for a central nervous system glioblastoma, the diabetic macular edema resolved.
Conclusion:
Systemic bevacizumab may result in the resolution of macular edema secondary to diabetes.
More Related Videos
08:10An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
Published on: January 25, 2019
09:24Three-dimensional Angiogenesis Assay System using Co-culture Spheroids Formed by Endothelial Colony Forming Cells and Mesenchymal Stem Cells
Published on: September 18, 2019
Related Concept Videos
Diabetic Retinopathy
Cytotoxic Edema: Pathophysiology
Diabetic Foot Ulcer